In the fourth quarter of 2024, the company reported a net profit of €813 million, a significant improvement from a €33 million loss in the
As of early 2025, Dr. Reddy’s Laboratories, headquartered in Hyderabad, India, has demonstrated robust financial performance. In the quarter ending December 31, 2024, the company
